SBS Calendar

Dr. Hugo Vilchis is the Director of the Border Epidemiology & Environmental Health Center at New Mexico State University. He is Associate Professor at New Mexico State University with the Health Science Department (College of Health and Social Services) and with the Molecular Biology Graduate program. He is also a Professor at El Colegio de Chihuahua and the Universidad Autónoma de Coahuila, higher education and research institutions in Mexico.

He obtained his medical degree from the National Autonomous University of Mexico in 1982 and his MPH from the School of Public Health of Mexico in 1985. Dr. Vilchis studied Epidemiology and Surveillance in Brazil in 1986.

Dr. Vilchis' public health career started in Mexico City in 1980 working for the General Directorate of Epidemiology, Mexican Secretary of Health. He was Department Chief of the National Immunization Programs in Mexico and during his tenure, children immunization rates rose to 90%. In 1989, he was appointed to the Pan American Health Organization, first as the National Advisor for the Immunization Program in Mexico and in 1992 as the Medical Epidemiologist of the Field Office in El Paso, Texas. In 1996, Dr. Vilchis joined New Mexico State University and the NM Office of Border Health, where he developed the Border Epidemiology & Environmental Health Center.

He has been working on many different projects involving epidemiology, surveillance, community health, and international health. Dr. Vilchis obtained his expertise working in the United States and Latin American countries like Mexico, Brazil, and Guatemala, among many others.

Elizabeth (Betz) Halloran
Professor in Biostatistics, Fred Hutchinson Cancer Research Center

This is the first educational seminar sponsored by the Hiroshima International Council for Health Care of Radiation-Exposed (HICARE) in Seattle. The Council has been sending a medical team to the Pacific Northwest to provide A-bomb survivors with health examinations every other year. Another important mission is to educate the people in the world about the danger of and health effects from A-bombs, in order to prevent the future use of nuclear weapons in the world. It is a rare and important opportunity to listen to medical and research experts who have been directly involved with A-bomb survivors in Hiroshima and Nagasaki.

Coffee and snacks will be served starting at 6:00pm

Parking is available at the S1 parking lot. When passing by the S1 Gate - please let the attendant know that you will be attending the seminar called "A-bomb Symposium". You pay on your way out.

Parking fee information: http://www.washington.edu/facilities/transportation/commuterservices/fees/gatehouse-permits

Click here for Map with details

Nicole L. Glazer, PhD, Epidemiologist, UW, CHRU

Brief bio: Dr. Glazer received her Ph.D. in epidemiology from the University of Washington. She currently works as a cardiovascular epidemiologist at the UW Cardiovascular Health Research Unit. Her areas of interest include genetics, biomarkers and pharmacoepidemiology. In her post-graduate work she has mostly focused on genome-wide association studies.

Recommended reading:

1. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA. 2008;299:1335-44.
2. Newton-Cheh C, et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet. 2009;41:399-406.

Adrian Raftery
Blumstein-Jordan Professor of Statistics and Sociology, Department of Statistics, University of Washington

Howard K. Koh, MD, MPH
Assistant Secretary for Health
U.S. Department of Health and Human Services

http://www.hhs.gov/ophs/leadership/ash.html

Annette Fitzpatrick, PhD

Update on the PRC Cardiovascular Health Intervention Research and Translation Network (CHIRTN)

Communicating with Pictures: Using Photovoice to Portray Perceptions of Cardiovascular Disease in Asian Immigrants

Please RSVP

Departmental holiday potluck for faculty and staff.

http://depts.washington.edu/hserv/holiday/party.htm

Mark Doescher, MD, MSPH
Director of WWAMI Rural Health Research Center and Center for Health Workforce Studies

• 3:00-3:30pm Regular Faculty ONLY
• 3:30-4:30pm All Faculty & Staff
• 4:30-5:00pm Social

AHRQ Issues Funding Opportunity Announcement (R01) for Comparative Effectiveness Research

Dear Colleague:

We are pleased to inform you about a Funding Opportunity Announcement (FOA) issued on September 25 by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ). RFA-HS-10-003, Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) Grants (R01), is supported by $100 million in funds provided to AHRQ under the American Recovery and Reinvestment Act of 2009.

The FOA invites grant applications for new comparative effectiveness research projects aimed at generating new knowledge to help inform decisionmaking in priority areas of clinical care. Projects should be focused on developing new scientific evidence that will fill important knowledge gaps and on generating critical insights into the comparative clinical effectiveness of health care interventions. Applications should address the outcomes and effectiveness of assessments across population groups that are often underrepresented in medical research. The impact of these studies should have a high likelihood of creating major advancements in clinical care. The initiative will emphasize projects that define research gaps and studies that are designed to produce actionable results.

AHRQ anticipates making 10 awards that together total $100 million, contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the proposed research will vary across applications, it is anticipated that each award's size and duration will vary. Applications may be up to 3 years in duration, with a total budget not to exceed $10 million over the 3 years. While total annual costs may vary over the award period, the maximum cost in any one year cannot exceed $4 million. Funding beyond the first year will be contingent upon the Agency's acceptance of the grantee's annual progress report. Applications are due on December 16, 2009.

Questions about this FOA can be submitted to: CHOICEgrants@ahrq.hhs.gov

Dear Colleague:

We are pleased to inform you about a Funding Opportunity Announcement (FOA) issued on September 25 by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ). RFA-HS-10-004, Innovative Adaption and Dissemination of AHRQ Comparative Effectiveness Research Products (iADAPT) (R18) is supported by $29.5 million in funds provided to AHRQ under the American Recovery and Reinvestment Act of 2009.

The FOA invites grant applications for new projects to extend the reach and impact of Comparative Effectiveness Research Reviews and associated products, particularly Comparative Effectiveness Research Summary Guides, which are prepared by the John M. Eisenberg Clinical Decisions and Communications Science Center, part of the AHRQ Effective Health Care Program. AHRQ seeks innovative efforts to adapt the content and/or delivery mechanism of one or more of its current or forthcoming comparative effectiveness research products, particularly summary guides. Adaptations should aim to increase the impact and effective use of one or more comparative effectiveness research products by developing, implementing, and evaluating product adaptations that target three important audiences: stakeholders, systems, and settings. The adaptations may involve customizing the original comparative effectiveness research contents to a specialized clinical audience of potential users or translating the Comparative Effectiveness Research Summary Guides for underserved patient and consumer populations who have limited access to medication information on the Internet. These consumers and patients are more likely to get health care information and advice provided through traditional means, such as neighborhood, community, or faith-based groups. Adaptations may address the presentation of the content and/or mechanisms by which the contents are delivered or used.

AHRQ anticipates making 20 to 25 awards that together total $29.5 million, contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the proposed research will vary across applications, it is anticipated that each award's size and duration will vary. Applications may be up to 3 years in duration, with a total budget not to exceed $1.5 million over the 3 years. While total annual costs may vary over the period of the award, the maximum cost in any one year cannot exceed $1 million. Funding beyond the first year will be contingent upon the Agency's acceptance of the annual progress report. Applications are due on December 16, 2009.

Questions about this FOA can be submitted to: iADAPTgrants@ahrq.hhs.gov

• 3:00-3:30pm Regular Faculty ONLY
• 3:30-4:30pm All Faculty & Staff
• 4:30-5:00pm Social

University is closed on official holidays

• 3:00-3:30pm Regular Faculty ONLY
• 3:30-4:30pm All Faculty & Staff
• 4:30-5:00pm Social

• 3:00-3:30pm Regular Faculty ONLY
• 3:30-4:30pm All Faculty & Staff
• 4:30-5:00pm Social